2-溴-1,3,5-三嗪-2-三苯基苯 | 10368-73-7

• 物质功能分类: 有机原料
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-溴-1,3,5-三嗪-2-三苯基苯
• 英文名称: 2-bromo-1,3,5-triphenylbenzene
• 英文别名: 2,4,6-triphenylbromobenzene；1-bromo-2,4,6-triphenylbenzene
• CAS: 10368-73-7
• 化学式: C₂₄H₁₇Br
• 分子量: 385.303
• InChiKey: JQAGNDRJKSDTEU-UHFFFAOYSA-N

物化性质

• 熔点：
  128.0 to 132.0 °C
• 沸点：
  479.7±14.0 °C(Predicted)
• 密度：
  1.278±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  7.5
• 重原子数：
  25
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

安全信息

• 海关编码：
  2903999090
• 危险性防范说明：
  P264,P270,P273,P280,P301+P312,P305+P351+P338,P330,P337+P313,P501
• 危险性描述：
  H302,H319,H413
• 储存条件：
  室温且干燥环境下使用。

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : 1-BROMO-2,4,6-TRIPHENYLBENZENE
CAS-No. : 10368-73-7
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Acute toxicity, Oral (Category 4)
Eye irritation (Category 2)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Harmful if swallowed. Irritating to eyes.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram
Signal word Warning
Hazard statement(s)
H302 Harmful if swallowed.
H319 Causes serious eye irritation.
Precautionary statement(s)
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s)
R-phrase(s)
R22 Harmful if swallowed.
R36 Irritating to eyes.
S-phrase(s)
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C24H17Br
Molecular Weight : 385,31 g/mol
Component Concentration
1-BROMO-2,4,6-TRIPHENYLBENZENE
CAS-No. 10368-73-7 -

---

Section 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly
investigated.
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIRE-FIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, Hydrogen bromide gas
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end uses
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at
the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested and
approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the
standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges. Use
respirators and components tested and approved under appropriate government standards such as
NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 7,824
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion Harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes Causes serious eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly
investigated.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

---

SECTION 15 - REGULATORY INFORMATION
N/A

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

1-溴-2,4,6-三苯基苯用于作为研究用化合物。

反应信息

• 作为反应物：
  描述：

  2-溴-1,3,5-三嗪-2-三苯基苯 在 正丁基锂 、 四氯化硅 作用下， 以 乙醚 、 正己烷 为溶剂， 反应 8.0h， 生成 9,9-dichloro-1,3-diphenyl-9-silafluorene
  参考文献：
  名称：

  Synthesis and Photophysical Properties of Asymmetric Substituted Silafluorenes

  摘要：

  Several 1,3-diphenyl-substituted silafluorene compounds were synthesized and characterized as potential fluorescent materials for OLED fabrication and bioimaging. Introducing phenyl groups into the silafluorene ring at the land 3-positions led to a red shift in the emission, resulting in blue light emitting compounds (lambda(max) 368-375 nm in solution; lambda(max) 362-371 and 482 nm in the solid state), and improved the quantum yield efficiency both in solution and as solids. Aggregation enhanced emission of the silafluorenes (AEE) was also investigated. Theoretical MO calculations were carried out to aid in understanding the optical properties of these molecules. Since these compounds might be useful in bioimaging, their toxicity was also investigated in skin fibroblast cells. All compounds were found to be nontoxic to the investigated cell cultures.

  DOI：

  10.1021/om300891n
• 作为产物：
  描述：

  1,3,5-三苯基苯 在 溴 、 溶剂黄146 作用下， 以 二氯甲烷 为溶剂， 反应 16.0h， 以93%的产率得到2-溴-1,3,5-三嗪-2-三苯基苯
  参考文献：
  名称：

  用于双功能催化的配体AZARYPHOS家族：合成和在钌催化的末端炔烃抗Markovnikov水合中的合成和使用

  摘要：

  引入了AZARYPHOS（氮杂-芳基-膦）膦配体家族，该膦配体在配体的外围具有膦单元和空间屏蔽的氮孤对，是通过配体球中的金属中心和氮孤对发展双官能催化的工具。已开发出通用的合成策略来合成25种结构多样的（6-芳基-2-吡啶基）膦（ARPYPHOS），（6-烷基-2-吡啶基）膦（ALPYPHOS），4,6-二取代1,3的实例-二氮杂-2-基膦或1,3,5-三嗪-2-基膦，喹唑啉基膦，喹啉基膦等。可扩展的合成过程分几步进行。将AZARYPHOS配体（L）掺入配合物[RuCp（L）2（MeCN）] [PF 6]（Cp =环戊二烯基）给出了已知活性最高的末端炔烃的反马尔科夫尼科夫水合反应的催化剂。电子和空间配体效应在两个数量级的范围内调节反应动力学。这些结果突出了在通过金属及其配体发展合作性双官能催化的过程中使用结构多样的配体家族的重要性。

  DOI：

  10.1002/chem.200900563
• 作为试剂：
  描述：

  四氢呋喃 、 1,3,5-三苯基苯 在 2-溴-1,3,5-三嗪-2-三苯基苯 、 calcium 作用下， 以91%的产率得到[(thf)3Ca{µ-C6H3-1,3,5-Ph3}Ca(thf)3]
  参考文献：
  名称：

  Krieck, Sven; Goerls, Helmar; Yu, Lian, Journal of the American Chemical Society, 2009, vol. 131, p. 2977 - 2985

  摘要：

  DOI：

文献信息

• Design of a Brønsted acid with two different acidic sites: synthesis and application of aryl phosphinic acid–phosphoric acid as a Brønsted acid catalyst
  作者：N. Momiyama、T. Narumi、M. Terada

  DOI：10.1039/c5cc06787a

  日期：——

  A Brønsted acid with two different acidic sites, aryl phosphinic acid–phosphoric acid, was synthesized and its catalytic performance was assessed.

  一种具有两个不同酸性位点的Brønsted酸，芳基膦酸-磷酸，已合成并评估了其催化性能。
• A Planar-Chiral Phosphino(alkenyl)ferrocene for Suzuki-Miyaura C-C Coupling Reactions
  作者：Dieter Schaarschmidt、Martin Grumbt、Alexander Hildebrandt、Heinrich Lang

  DOI：10.1002/ejoc.201402861

  日期：2014.10

  applied in the presence of palladium in Suzuki–Miyaura couplings for the synthesis of sterically congested biaryls. The catalytic activity arises from homogeneous palladium phosphine complexes, of which the potential pre-catalyst [Pd(4)2Cl2] was characterized structurally. The catalytic system is excellently suited for the synthesis of tri-ortho-substituted biaryls under mild conditions (0.1 mol-%, 50–100

  平面手性膦二茂铁 [Fe(η5-C5H3-1-PPh2-2-(E)-CH=CHPh)(η5-C5H5)] (4) 在 Suzuki-Miyaura 偶联中钯存在下用于合成空间拥挤的联芳基化合物。催化活性来自均相钯膦配合物，其中潜在的预催化剂 [Pd(4)2Cl2] 的结构特征。该催化体系非常适合在温和条件下（0.1 mol%，50-100 °C）合成三邻位取代的联芳基化合物，但其在合成四邻位取代的联芳基化合物方面的应用非常有限。将反应性能与 4 作为催化剂和一系列具有不同邻位取代基的底物进行比较，表明金属转移是速率决定因素。复合物 (Sp)-4 用于 atropselective 耦合，其中实现了高达 36% 的对映体富集。立体选择性在一定程度上取决于硼酸的空间性质；然而，芳基卤化物的微小变化会影响对映选择性。
• Evaluation of the Transferability of the “Flexible Steric Bulk” Concept from N‐Heterocyclic Carbenes to Planar‐Chiral Phosphinoferrocenes and their Electronic Modification
  作者：Marcus Korb、Dieter Schaarschmidt、Martin Grumbt、Matthias König、Heinrich Lang

  DOI：10.1002/ejic.202000414

  日期：2020.8.23

  concept of “flexible steric bulk” is discussed at 2‐phenylvinyl‐1‐phosphinoferrocenes. The introduction of freely rotatable 1'‐silyl groups increases the catalytic productivity within the synthesis of tri‐ortho‐substituted biaryls by Suzuki–Miyaura C,C cross‐coupling reactions, giving higher yields with 1/4 of catalyst concentration than for the non‐silylated derivatives. Electronic modification of

  在2-苯基乙烯基-1-膦基二茂铁中讨论了“柔性空间本体”的概念。引进的可自由转动的1'-甲硅烷基增加了合成中的催化生产率的三-邻位通过铃木-宫浦取代的联芳基C，C的交叉偶联反应，得到更高的产率1/4催化剂浓度比用于非甲硅烷基化衍生物。通过在两个基团的对位引入取代基来研究P和乙烯基供体官能团的电子修饰。其中，对于给定的联芳基，吸电子膦通过将二苯基膦改成P（p -CN-C 6 H4）2个单位。从给电子体和空间需求的膦中获得的相反结果与1 J（31 P，77 Se）值一致。然而，二茂铁基骨架的电子密度，由第一个与二茂铁基相关的氧化还原过程的氧化还原电势表示，不能与P原子的给体性质相关。从PPh 2取代的二茂铁变为（R A）-1,1'-联萘基亚膦酸酯，轴向和平面手性基序之间发生复杂的相互作用，从而导致绝对联芳基构型的改变。
• Palladium-Catalyzed Asymmetric Phosphination. Scope, Mechanism, and Origin of Enantioselectivity
  作者：Natalia F. Blank、Jillian R. Moncarz、Tim J. Brunker、Corina Scriban、Brian J. Anderson、Omar Amir、David S. Glueck、Lev N. Zakharov、James A. Golen、Christopher D. Incarvito、Arnold L. Rheingold

  DOI：10.1021/ja070225a

  日期：2007.5.1

  initiated by oxidative addition to Pd(0) yielding Pd((R,R)-Me-Duphos)(Ph)(I) (3). Reversible displacement of iodide by PHMe(Is) gave the cation [Pd((R,R)-Me-Duphos)(Ph)(PHMe(Is))][I] (4), which was isolated as the triflate salt and crystallographically characterized. Deprotonation of 4-OTf with NaOSiMe3 gave the phosphido complex Pd((R,R)-Me-Duphos)(Ph)(PMeIs) (5); an equilibrium between its diastereomers

  芳基碘化物 (ArI) 与仲芳基膦 (PHMe(Ar'), Ar' = (2,4,6)-R3C6H2; R = i-Pr (Is), Me (Mes), Ph (Phes) 的不对称交叉偶联)) 在碱 NaOSiMe3 和手性 Pd 催化剂前体，如 Pd((R,R)-Me-DuphOS)(trans-stilbene) 的存在下，得到叔膦 PMe(Ar')(Ar)形式。空间要求高的仲膦取代基 (Ar') 和带有给电子对位取代基的芳基碘化物导致最高的对映体过量，高达 88%。邻位取代芳基碘化物的膦化需要 Pd(Et-FerroTANE) 催化剂，但对映选择性较低。催化过程中的观察和各个步骤的化学计量研究表明，PhI 和 PHMe(Is) (1) 交叉偶联的机制是通过氧化加成到 Pd(0) 产生 Pd((R, R)-Me-DuphOS)(Ph)(I) (3)。PHMe(Is) 对碘化物的可逆置换得到阳离子
• Highly Enantioselective Synthesis of Functionalized Glutarimide Using Oxidative N-Heterocyclic Carbene Catalysis: A Formal Synthesis of (−)-Paroxetine
  作者：Arka Porey、Surojit Santra、Joyram Guin

  DOI：10.1021/acs.joc.9b00320

  日期：2019.5.3

  yet highly effective approach toward enantioselective synthesis of trans-3,4-disubstituted glutarimides from readily available starting materials is developed using oxidative N-heterocyclic carbene catalysis. The catalytic reaction involves a formal [3 + 3] annulation between enals and substituted malonamides enabling the production of glutarimide derivatives in a single chemical operation via concomitant

  利用氧化的N-杂环卡宾催化，开发了一种简单而高效的方法，可从容易获得的起始原料中进行对映选择性合成反式3,4-二取代的戊二酰亚胺。催化反应包括在烯醛和取代的丙二酰胺之间进行正式的[3 + 3]环化反应，从而可以通过同时形成C–C和C–N键在单个化学操作中生成戊二酰亚胺衍生物。该反应可轻松获得具有出色的对映选择性和良好收率的多种功能化戊二酰亚胺。通过（-）-帕罗西汀和其他生物活性分子的正式合成证明了该方法的合成应用。